I agree that this site is using cookies. You can find further informations here.
X
Klova, Amy L.
5  results:
Search for persons X
?
1

Thyromimetics improve disease endpoints and modulate potent..:

Woerner, Michaelanne ; Vivian, Jeffrey ; Alavi, Aryan...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
2

Molecular characterization of type I IFN-induced cytotoxici..:

Green, Jennifer L. ; Osterhout, Robin E. ; Klova, Amy L....
Molecular Therapy - Oncolytics.  23 (2021)  - p. 547-559 , 2021
Link: https://doi.org/10.1016/..
 
?
3

ABX-002: A fatty-acid amide hydrolase (FAAH) activated prod..:

MacKenna, Deidre ; Danks, Anne ; Akhtar, Waseem...
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
4

Molecular characterization of type I IFN-induced cytotoxici..:

Green, Jennifer L ; Osterhout, Robin E ; Klova, Amy L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645427/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

Molecular characterization of type I IFN-induced cytotoxici..:

Jennifer L. Green ; Robin E. Osterhout ; Amy L. Klova...
http://www.sciencedirect.com/science/article/pii/S2372770521001558.  , 2021
Link: https://doi.org/10.1016/..
 
1-5